| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |